De Burlo Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,625
Closed -$1.4M 100
2021
Q2
$1.4M Sell
7,625
-400
-5% -$73.5K 0.22% 58
2021
Q1
$1.23M Sell
8,025
-400
-5% -$61.2K 0.22% 60
2020
Q4
$1.32M Sell
8,425
-75
-0.9% -$11.7K 0.22% 56
2020
Q3
$9.72M Buy
8,500
+2,250
+36% +$2.57M 1.77% 27
2020
Q2
$561K Hold
6,250
0.16% 52
2020
Q1
$561K Sell
6,250
-300
-5% -$26.9K 0.16% 52
2019
Q4
$708K Sell
6,550
-700
-10% -$75.7K 0.14% 65
2019
Q3
$710K Sell
7,250
-9,010
-55% -$882K 0.16% 60
2019
Q2
$2.13M Sell
16,260
-300
-2% -$39.3K 0.42% 52
2019
Q1
$2.24M Sell
16,560
-2,850
-15% -$385K 0.45% 51
2018
Q4
$1.89M Sell
19,410
-586
-3% -$57K 0.42% 54
2018
Q3
$2.78M Hold
19,996
0.52% 55
2018
Q2
$2.48M Sell
19,996
-100
-0.5% -$12.4K 0.53% 49
2018
Q1
$2.24M Hold
20,096
0.49% 49
2017
Q4
$2.4M Sell
20,096
-354
-2% -$42.3K 0.49% 55
2017
Q3
$2.87M Sell
20,450
-100
-0.5% -$14K 0.64% 45
2017
Q2
$2.5M Sell
20,550
-400
-2% -$48.7K 0.56% 44
2017
Q1
$2.54M Sell
20,950
-4,664
-18% -$565K 0.55% 48
2016
Q4
$3.13M Sell
25,614
-2,070
-7% -$253K 0.76% 45
2016
Q3
$3.39M Sell
27,684
-50
-0.2% -$6.13K 0.94% 46
2016
Q2
$3.24M Sell
27,734
-12,825
-32% -$1.5M 0.78% 47
2016
Q1
$5.65M Sell
40,559
-16,900
-29% -$2.35M 1.63% 19
2015
Q4
$11M Buy
57,459
+5,389
+10% +$1.03M 2.58% 8
2015
Q3
$8.14M Sell
52,070
-525
-1% -$82.1K 1.91% 19
2015
Q2
$9.51M Sell
52,595
-14,950
-22% -$2.7M 1.99% 14
2015
Q1
$11.7M Sell
67,545
-9,250
-12% -$1.6M 2.32% 10
2014
Q4
$14.2M Buy
76,795
+1,600
+2% +$296K 2.87% 4
2014
Q3
$12.5M Buy
75,195
+4,020
+6% +$667K 2.76% 6
2014
Q2
$11.1M Buy
71,175
+225
+0.3% +$35.2K 2.52% 9
2014
Q1
$10.8M Sell
70,950
-2,700
-4% -$411K 2.6% 10
2013
Q4
$9.79M Sell
73,650
-55,250
-43% -$7.34M 2.34% 10
2013
Q3
$15M Sell
128,900
-925
-0.7% -$107K 4.08% 1
2013
Q2
$12M Buy
+129,825
New +$12M 3.55% 3